Green light from Health Canada advances VIVO Cannabis’s planned doubling of cannabis production capacity

Anisha Dhiman - thegrowthop.com Posted 5 years ago
image

VIVO Cannabis Inc. reports the company’s wholly owned subsidiary, ABcann Medicinals Inc., has received the thumbs-up from Health Canada to begin cultivation in the expansion of its Napanee, Ont. facility.

 

  • The largest drugstore chain in the U.S. announces plans to sell cannabis products
  • The man who co-invented Viagra is now developing cannabis products so women can have better sex
  • A Native American tribe has become Las Vegas’ most unlikely cannabis powerhouse

 

The approval will allow for doubling of VIVO’s Ontario cultivation capacity, notes a statement from the Napanee-based company, which holds production and sales licences from Health Canada and operates indoor cultivation facilities.

Current production capacity is now more than 5,000 kg and it is “anticipated to further increase to 11,000 kg later in 2019 following the completion and licensing of ongoing, fully funded expansion projects in Hope, B.C. and Napanee, Ont.,” the press release states. “This capacity will be augmented by several thousand additional kilograms sourced from third-party cultivators that meet VIVO’s rigorous quality standards,” it adds.

1a GettyImages 491441076 e1553271992223 Green light from Health Canada advances VIVO Cannabis’s planned doubling of cannabis production capacity

FILE: A man inspects a product with a magnifying glass at a marijuana dispensary in Portland, Oregon, on October 4, 2015.

Noting that cultivation in the expanded area will start immediately, the “expansion includes production and product development space built to GMP (good manufacturing practices) standards,” VIV reports. “A supercritical CO2 extraction suite for production of concentrates has been incorporated into the facility and is expected to be brought online mid-2019,” the company adds.

“The GMP certification of our Vanluven expansion, expected later this year, will enable us to service the growing international medical cannabis market,” comments VIVO CEO Barry Fishman. “Through our internal expansion projects (including indoor facilities, seasonal greenhouses and outdoor growing) and certified third-party partners, we are well-positioned to increase our offering of premium products in Canada’s medical and adult-use markets, including launching new formats such as edibles, concentrates and precisely dosed medical products when they are permitted by regulations,” Fishman adds.

 

Want to keep up to date on what’s happening in the world of cannabis?  Subscribe to the Cannabis Post newsletter for weekly insights into the industry, what insiders will be talking about and content from across the Postmedia Network.